Two Sigma Investments, LP Vascular Biogenics Ltd. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.15 - $0.27 $2,265 - $4,077	15,100 Added 84.83%	32,900 $7,000
Q1 2023 May 15, 2023	SELL	$0.13 - $0.19 $13,364 - $19,532	-102,800 Reduced 85.24%	17,800 $3,000
Q4 2022 Feb 14, 2023	SELL	$0.11 - $0.16 $33,593 - $48,862	-305,393 Reduced 71.69%	120,600 $14,000
Q3 2022 Nov 14, 2022	BUY	$0.15 - $2.1 $63,898 - $894,585	425,993 New	425,993 $66,000
Q1 2021 May 17, 2021	SELL	$1.79 - $2.91 $36,150 - $58,770	-20,196 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.07 - $2.0 $21,609 - $40,392	20,196 New	20,196 $38,000
Q4 2018 Feb 14, 2019	SELL	$0.6 - $1.72 $13,140 - $37,668	-21,900 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.55 - $2.17 $20,770 - $29,078	-13,400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.05 - $3.0 $27,469 - $40,200	13,400 New	13,400 $29,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.